Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Paycom Software (PAYC) shares advanced as KeyBanc upgraded the stock and raised the price target on optimism about sales, ...
Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...
Stock futures and bond yields fell early on Monday after President Trump did not rule out the possibility that his policies would cause a recession and data showed deflationary pressures building in ...
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical ...